38 results on '"Niego, Be'eri"'
Search Results
2. A novel ex vivo approach for measuring plasminogen activation upon established plasma clots
3. Assessment of the epi-pericardial fibrotic substrate by collagen-targeted probes
4. Molecular imaging of atrial myopathy: Towards early AF detection and non-invasive disease management
5. Tranexamic acid modulates the cellular immune profile after traumatic brain injury in mice without hyperfibrinolysis
6. An Engineered Nanosugar Enables Rapid and Sustained Glucose‐Responsive Insulin Delivery in Diabetic Mice (Adv. Mater. 21/2023)
7. Polyphenol‐Functionalized Cubosomes as Thrombolytic Drug Carriers
8. Platelet-targeted thrombolysis for treatment of acute ischemic stroke
9. t-PA–specific modulation of a human blood-brain barrier model involves plasmin-mediated activation of the Rho kinase pathway in astrocytes
10. Bioresponsive Polyphenol-Based Nanoparticles as Thrombolytic Drug Carriers
11. Targeting shear gradient activated von Willebrand factor by the novel single-chain antibody A1 reduces occlusive thrombus formation in vitro
12. Thrombin-induced activation of astrocytes in mixed rat hippocampal cultures is inhibited by soluble thrombomodulin
13. Collagen‐Targeted Peptides for Molecular Imaging of Diffuse Cardiac Fibrosis
14. A nonfibrin macromolecular cofactor for tPA-mediated plasmin generation following cellular injury
15. Tissue-Type Plasminogen Activator and Tenecteplase-Mediated Increase in Blood Brain Barrier Permeability Involves Cell Intrinsic Complement
16. Plasmin Generation Potential and Recanalization in Acute Ischaemic Stroke; an Observational Cohort Study of Stroke Biobank Samples
17. Applications of Nanotechnology in the Diagnosis and Therapy of Stroke
18. Shear-Dependent Platelet Aggregation: Mechanisms and Therapeutic Opportunities
19. Limiting Neuronal Nogo Receptor 1 Signaling during Experimental Autoimmune Encephalomyelitis Preserves Axonal Transport and Abrogates Inflammatory Demyelination
20. t-PA Suppresses the Immune Response and Aggravates Neurological Deficit in a Murine Model of Ischemic Stroke
21. Applications of Nanotechnology in the Diagnosis and Therapy of Stroke.
22. 011 Ex-vivo generation of plasmin from patients with acute ischaemic stroke is predictive of successful thrombolysis
23. LDL receptor blockade reduces mortality in a mouse model of ischaemic stroke without improving tissue-type plasminogen activator-induced brain haemorrhage: towards pre-clinical simulation of symptomatic ICH
24. Studies into the interaction between the plasminogen activating system and the blood-brain barrier
25. Selective inhibition of brain endothelial Rho-kinase-2 provides optimal protection of an in vitro blood-brain barrier from tissue-type plasminogen activator and plasmin
26. Novel Thrombolytic Drug Based on Thrombin Cleavable Microplasminogen Coupled to a Single‐Chain Antibody Specific for Activated GPIIb/IIIa
27. Limiting Neuronal Nogo Receptor 1 Signaling during Experimental Autoimmune Encephalomyelitis Preserves Axonal Transport and Abrogates Inflammatory Demyelination.
28. The Influence of Differentially Expressed Tissue-Type Plasminogen Activator in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis
29. Plasmin-Dependent Modulation of the Blood–Brain Barrier: A Major Consideration during tPA-Induced Thrombolysis?
30. Improved Method for the Preparation of a Human Cell-based, Contact Model of the Blood-Brain Barrier
31. Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function
32. Desmoteplase-mediated plasminogen activation and clot lysis are inhibited by the lysine analogue tranexamic acid
33. Two conserved regions within the tissue-type plasminogen activator gene promoter mediate regulation by brain-derived neurotrophic factor
34. Oncostatin M is a neuroprotective cytokine that inhibits excitotoxic injury in vitro and in vivo
35. Effective treatment of mouse metastatic prostate cancer by low electric field enhanced chemotherapy
36. Molecular Imaging of Diffuse Cardiac Fibrosis with a Radiotracer That Targets Proteolyzed Collagen IV.
37. Targeting shear gradient activated von Willebrand factor by the novel single-chain antibody A1 reduces occlusive thrombus formation in vitro.
38. t-PA, but not desmoteplase, induces plasmin-dependent opening of a blood-brain barrier model under normoxic and ischaemic conditions.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.